Carbon-based engineered nanomaterials (ENM), including carbon nanotubes (CNT), graphene, and fullerenes, have profound utility in medicine, electronics, and composites. While the surface is just being scratched on the diverse applications, a growing workforce is subject to exposure by inhalation. In vivo studies identify pulmonary cytotoxicity, inflammation, and fibrosis as a result of carbon-based ENM exposure. In addition to the pulmonary response, effects related to cardiovascular dysfunction included vascular inflammation and oxidative stress, endothelial dysfunction, and increased atherosclerotic plaque formation. The mechanisms linking the initial pulmonary exposure to resultant cardiovascular dysfunction are under investigation. Given the apparent toxicity of certain ENM and the vast number of ENM including various permutations of each, controlled toxicology studies in humans are not practical. Therefore, a translational in vitro screening assay was developed for rodents to assess the potential cardiovascular toxicity of ENM. Specifically, this particular study explored the ability of circulating factors after pulmonary exposure to affect mechanisms related to vascular dysfunction. Serum collected from mice exposed to carbon black, multi-walled CNT, or varying types of graphene were incubated with murine primary endothelial cells. The serum from exposed mice increased endothelial cell surface expression of VCAM-1 and ICAM-1 as early as 4 hr post-exposure when compared to respective shams. In addition, the serum from exposed mice reduced ATP-stimulated endothelial cell nitric oxide production by 25%. These results complement end point cardiovascular effects and showed the presence of circulating factors contributing to vascular dysfunction following carbon-based ENM exposure. Furthermore, the methodological design allows for interpretation of systemic effects in an unbiased approach while providing a platform for comparative studies of differing ENM in a translational context.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.